Kai Kang

59 papers and 1.4k indexed citations i.

About

Kai Kang has authored 59 papers that have received a total of 1.4k indexed citations. This includes 21 papers in Molecular Biology, 15 papers in Infectious Diseases and 13 papers in Neurology. The topics of these papers are COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (11 papers) and Heme Oxygenase-1 and Carbon Monoxide (8 papers). Kai Kang is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (11 papers) and Heme Oxygenase-1 and Carbon Monoxide (8 papers) and collaborates with scholars based in China, New Zealand and United States. Kai Kang's co-authors include Shangha Pan, Mingyan Zhao, Dongsheng Fei, Xianglin Meng and Kaijiang Yu and has published in prestigious journals such as PLoS ONE, Biomaterials and Frontiers in Immunology

In The Last Decade

Rankless by CCL
2025